Credits Available: 4.75 hours of AMA PRA Category 1 Credit™; ABIM MOC

Description: Despite significant advancements in treatment, multiple myeloma remains an incurable disease, and nearly all patients experience relapse, often requiring increasingly complex therapeutic strategies.

With the rapid expansion of treatment options, particularly novel targeted therapies such as GPRC5D-directed approaches, the landscape of relapsed/refractory multiple myeloma (RRMM) management is evolving at an unprecedented pace. While these agents offer deep and durable remissions, their integration into clinical practice presents challenges in sequencing, toxicity management, and multidisciplinary coordination.

This educational initiative is designed to empower clinicians with the latest insights on GPRC5D-targeted therapies, facilitate the exchange of real-world clinical experience, and provide actionable strategies for optimizing patient outcomes. Through interactive discussions and expert-led guidance, participants will gain practical knowledge to navigate the complexities of RRMM treatment while fostering collaborative networks to enhance long-term patient care.

Join us to stay at the forefront of innovation in multiple myeloma management and elevate your clinical practice.

CME/CE Accreditation Information

If you already have a Gather-ed account, please login

Email:
Password:

Register

Step 1 of 3

This program is intended for:
Target Professions: DO, MD, Nurse Practitioner, Nurse, Physician Associate/Assistant
Target Specialties: Hematology, Hematology/Oncology, Oncology

Adrienne Phillips

Cooperman Barnabas Medical Center
Director of Cellular Therapy and BMT

Dr. Phillips is the Director of Cell Therapy and Bone Marrow Transplantation at RWJBarnabas Health and an Associate Professor of Medicine at Rutgers Robert Wood Johnson Medical School in New Brunswick, New Jersey, USA. She received her Medical Degree with honors from Brown University, and Master of Public Health from Harvard University. Dr. Phillips completed both her residency in Internal Medicine and fellowship in Hematology-Oncology at New York Presbyterian Hospital-Columbia. Her clinical and translational research focus is on treating patients with HTLV-Related Adult T-Cell Leukemia Lymphoma (ATLL) through stem cell transplantation.